Sp Group A/s · OMXCOP:SPG
Sp Group A/s — H1 2025 Earnings Presentation
19 slides from Sp Group A/s's earnings presentation, Aug 20, 2025
Slide 1: Interim report First half of 2025
Interim report First half of 2025 Lars Bering, CEO Tilde Kejlhof, CFO Innovative 20 August 2025 solutions in plastics SP Group
Slide 2: Forward-looking statements
Forward-looking statements This presentation contains forward-looking statements reflecting SP Group’s current perception of future trends and financial performance. Statements relating to 2025 and the following years are inherently subject to uncertainty, and SP Group’s actual results may thus diff
Slide 3: At a glance
At a glance Global manufacturer of plastics solutions SP Group’s sales in H1 2025 broken down by product group: 73% customer-specific 27% own products solutions Cleantech Global 30 Healthcare 27% 40% footprint factories 2,417 average number 9 different plastics Foodtech 12% of employees technologies
Slide 4: Highlights /1
Highlights /1 Strong growth in Q1 followed by a slowdown in Q2 • Sales dropped in H1, with Q1 being the best quarter in our history, while Q2 was marked by a slowdown in activity • H1 sales of own products fell but subsupplier projects were on an upward trend • Many new projects in Healthcare and Cl
Slide 5: Highlights /2
Highlights /2 Tariffs and trade war • New US/EU trade deal expected to have marginal impact only • Costs expected to be passed on to customers over time • Close dialogue with customers about production location changes Share buy-back programme and dividend • Increase of share buy-back programme from
Slide 6: H1 2025 Revenue, EBITDA, EBIT, own products
H1 2025 Revenue EBITDA DKKm DKKm 1,485 1,467 -1.2% -3.7% 230 302 291 1,370 H1 2023 H1 2024 H1 2025 H1 2023 H1 2024 H1 2025 EBIT Sales of own products DKKm DKKm 439 -5.0% -11.5% 203 192 388 317 130 H1 2023 H1 2024 H1 2025 H1 2023 H1 2024 H1 2025 SP Group H1 2025 – 20 August 2025 6
Slide 7: Profit before financial items (EBT) fell by 6.7%
H1 2025 Profit before financial items (EBT) fell by 6.7% Earnings per share, diluted, fell by 6.2% DKKm 176 11.33 10.63 154 165 9.92 130 8.20 108 6.92 H1 2021 H1 2022 H1 2023 H1 2024 H1 2025 H1 2021 H1 2022 H1 2023 H1 2024 H1 2025 Net interest-bearing debt (NIBD) fell by DKK 64 million Equity grew b
Slide 8: SP Meditec increases capacity
SP Meditec increases capacity Production facilities in Atlanta, USA • Atlanta factory in operation, ramp-up continues • ISO 13485 certified • 1,000 sqm of class 8 cleanroom facilities in operation • Contracts for new projects signed, securing continued growth • Strong growth opportunities for Health
Slide 9: Sales of own products reduced
Sales of own products reduced Own products include medical packaging, guide wires, farm Sales of own products ventilation, maritime products and ergonomic solutions DKKm -11.5% 439 391 388 317 317 H1 2021 H1 2022 H1 2023 H1 2024 H1 2025 SP Group H1 2025 – 20 August 2025 9
Slide 10: Sales in H1 2025 by customer group
Sales in H1 2025 by customer group Healthcare 40% Cleantech 27% Foodtech 12% Other 21% • Medical equipment • Renewable energy • Farm ventilation • Furniture • Medical packaging • Energy reduction • Measuring equipment • Specialist vehicles • Ergonomics and safety • Insulation products • Maritime pro
Slide 11: Financial ratios
Financial ratios DKKm Q2 2025 Q2 2024 Growth (%) Acc. Q2 2025 Acc. Q2 2024 Growth (%) Revenue 680.6 762.2 -10.7% 1,466.9 1,485.1 -1.2% EBITDA 124.8 153.7 -18.8% 291.1 302.1 -3.7% EBIT 75.2 103.9 -27.6% 192.3 202.5 -5.0% EBT 63.6 91.6 -30.6% 164.7 176.4 -6.7% EPS (DKK) 10.6 11.3 -6.2% Equity 1,701.2
Slide 12: Revenue performance
Revenue performance DKKm 2,922 2,904 • 1.2% revenue decline 2,656 2,606 (relative to H1 2024) 2,481 2,178 • Decline in Healthcare, Cleantech, 2,013 and Foodtech – growth in the 1,884 1,965 'Other' segment 1,519 1,320 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 R12M Revenue for 2025 is stated o
Slide 13: EBITDA and EBITDA margin performance
EBITDA and EBITDA margin performance DKKm 800 25 • EBITDA down by 3.7% 700 589 578 (relative to H1 2024) EBITDA-margin in % 600 20 • Driven by lower revenue and a EBITDA 478 changed product mix 500 423 441 15 400 356 286 308 275 10 300 203 200 163 5 100 0 0 2015 2016 2017 2018 2019 2020 2021 2022 20
Slide 14: EBT and EBT margin performance
EBT and EBT margin performance DKKm • EBT down by 6.7% % 500 12 (relative to H1 2024) EBT-margin in % 11 • Driven by lower revenue and a EBT 400 10 changed product mix 9 345 333 8 300 258 269 7 6 200 194 201 5 200 176 175 4 123 3 100 81 2 1 0 0 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 R12M
Slide 15: Outlook for 2025
Outlook for 2025 Revenue guidance for 2025 downgraded while earnings margins guidance maintained Original guidance in Updated guidance 2024 Annual Report at 10 July 2025 Revenue growth 3-10% -3 to +3% EBITDA margin 19-21% 19-21% EBT margin 11-13% 11-13% SP Group H1 2025 – 20 August 2025 15
Slide 16: New SP Group logo and website
New SP Group logo and website • New clean and timeless logo • Launch of new website: www.sp-group.dk SP Group H1 2025 – 20 August 2025 16
Slide 17: Summary
Summary • Satisfactory Q1 performance with record revenue, EBITDA margin and EBT margin • Lack of growth in Q2 due to postponed projects with own products and slowdown in sales to Healthcare, Foodtech and Cleantech • New US factory off to a good start • Share buy-back programme increased • New EU/US
Slide 18: Q&A session
Q&A session SP Group H1 2025 – 20 August 2025 18
Slide 19: Further information: Lars Bering CEO
Further information: Lars Bering CEO SP Group A/S Snavevej 6-10 5471 Søndersø Denmark Tel.: +45 7023 2379 / +45 4033 8850 E-mail: lb@sp-group.dk SP Group